Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01223
|
|||||
| Drug Name |
Mephenoxalone
|
|||||
| Synonyms |
5-((2-Methoxyphenoxy)methyl)oxazolidin-2-one; 5-(o-Methoxyphenoxymethyl)-2-oxazolidinone; 5-(o-Methoxyphenoxymethyl)-2-oxazolidone; AHR 233; Alkapol peg-400; CL 27,319; Control-OM; Dorsiflex; Dorsilon; EINECS 200-723-3; Ekilan; Lenetran; Lenetran TAB; Lenetranat; MEPHENOXALONE; Mefenoxalona; Mefenoxalona [INN-Spanish]; Mefenoxalone; Mephenoxalone [INN:DCF]; Mephenoxalonum [INN-Latin]; Methoxadone; Methoxydon; Methoxydon(E); Methoxydone; Metoxadone; Moderamin; Placidex; Riself; Transpoise; Trepidone; Valanas; Xerene
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Anxiety [ICD11: MB24.3] | Preclinical | [1] | |||
| Therapeutic Class |
Anxiolytic Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C11H13NO4
|
|||||
| Canonical SMILES |
COC1=CC=CC=C1OCC2CNC(=O)O2
|
|||||
| InChI |
InChI=1S/C11H13NO4/c1-14-9-4-2-3-5-10(9)15-7-8-6-12-11(13)16-8/h2-5,8H,6-7H2,1H3,(H,12,13)
|
|||||
| InChIKey |
ZMNSRFNUONFLSP-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 70-07-5
|
|||||
| Pharmaceutical Properties | Molecular Weight | 223.22 | Topological Polar Surface Area | 56.8 | ||
| Heavy Atom Count | 16 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
1.4
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:134916
|
|||||
| DT(s) Transporting This Drug | MATE1 | Transporter Info | Multidrug and toxin extrusion protein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Wikipedia: Mephenoxalone | |||||
| 2 | Preclinical and clinical evidence for the collaborative transport and renal secretion of an oxazolidinone antibiotic by organic anion transporter 3 (OAT3/SLC22A8) and multidrug and toxin extrusion protein 1 (MATE1/SLC47A1). J Pharmacol Exp Ther. 2010 Sep 1;334(3):936-44. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.